Determining the Minimal Clinically Important Difference of the 40-Item Smell Identification Test in People With Cystic Fibrosis

By afschroeder • March 14, 2026

Oh E, Miller JE, Lee MJ, Zemke A, Baraghoshi D, Strand MJ, Alt JA, Bodner TE, Chang M, Chowdhury NI, Eshaghian PH, Getz AE, Goralski JL, Gudis DA, Hwang PH, Khanwalkar A, Kimple AJ, Lee JT, Li DA, Mace JC, Nayak JV, Overdevest JB, Patel Z, Safatian DK, Schlosser RJ, Senior B, Stapleton AL, Smith TL, Soler ZM, Suh JD, Turner GA, Wang MB, Saavedra MT, Taylor-Cousar JL, Beswick DM. Determining the Minimal Clinically Important Difference of the 40-Item Smell Identification Test in People With Cystic Fibrosis. Int Forum Allergy Rhinol. 2026 Mar 13. doi: 10.1002/alr.70136. Epub ahead of print. PMID: 41830161.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic review of outcomes

Stirrat T, Wilkey M, Ransibrahmanakul V, Singh L, Allen O, Kanth P, Rangnekar A, Redfield R. Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic[...]

Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer

Silverstein J, Alomaja O, Chatram D, Hajiabbasi M, Shachar E, Tseng CH, Thaker S, Bardia A, Karlan B, Hendrickson AW, Konecny GE. Real-world clinical outcomes[...]

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial

Falchi L, Offner F, de Vos S, Brody JD, Morillo D, Linton K, Snauwaert S, Roost Clausen M, Karimi YH, Thieblemont C, Vitolo U, Leslie[...]